The use of essential drugs, TRS.685
[s.l.] :
Geneva WHO 1983, s.a.]
TRS (Series)
The use of essential drugs, TRS.722
[s.l.] :
Geneva WHO 1985, s.a.]
TRS (Series)
The use of essential drugs, TRS.770
[s.l.] :
Geneva WHO 1988, s.a.]
TRS (Series)
The use of essential drugs, TRS.796
[s.l.] :
Geneva WHO 1990, s.a.]
TRS (Series)
The use of essential drugs, TRS.825
[s.l.] :
Geneva WHO 1992, s.a.]
TRS (Series)
The use of essential drugs, TRS.867
[s.l.] :
Geneva WHO 1997, s.a.]
TRS (Series)
Evaluation of dependence producing drugs, TRS.287
[s.l.] :
Geneva WHO 1964, s.a.]
TRS (Series)
Evaluation and testing of drugs for mutagenicity: principles and problems, TRS.482
[s.l.] :
Geneva WHO 1971, s.a.]
TRS (Series)
Evaluation of dependence liability and dependence potential of drugs, TRS.577
[s.l.] :
Geneva WHO 1975, s.a.]
TRS (Series)
Principles for the testing and evaluation of drugs for carcinogenicity, TRS.426
[s.l.] :
Geneva WHO 1969, s.a.]
TRS (Series)